Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Nanotechnology research: Faster, cheaper COVID tests

Written by | 11 Apr 2022

A University of Georgia nanotechnology research groupentered the race to develop a rapid test for COVID-19 in August 2020, running experiments on a new sensor for an American… read more.

Researchers roll out data on COVID vaccine distribution and waste

Written by | 11 Apr 2022

Researchers are rolling out a data set that provides detailed information on COVID-19 vaccine shipments and wastage across the United States, with the goal of spurring new data… read more.

Saliva testing for COVID-19 quicker, safer than nasal swabs

Written by | 22 Mar 2022

Genetic testing of saliva samples identifies the SARS-CoV-2 virus more quickly than testing of nasal swabs. The research is published March 21 in Microbiology Spectrum, a journal of the American Society… read more.

A third of new mothers during early COVID had postpartum depression

Written by | 17 Mar 2022

One in three new mothers during early COVID-19 screened positive for postpartum depression — nearly triple pre-pandemic levels — and 1 in 5 had major depressive symptoms, say… read more.

Clinical trial reveals new treatment option for COVID-19

Written by | 16 Mar 2022

A clinical trial conducted by researchers from RCSI University of Medicine and Health Sciences and Beaumont Hospital Dublin has indicated an effective treatment for critically ill COVID-19 patients…. read more.

Mass media and building trust

Written by | 13 Mar 2022

Open discussion of the scientific evidence and the uncertainties could have generated less political polarisation, less wasted expenditure but built more trust, according to Allyson Pollock, Clinical Professor… read more.

Natural immunity and protecting children

Written by | 12 Mar 2022

Covid is far less serious for children, long-covid is not a big issue and many also have natural immunity – all of which raises questions over whether children… read more.

Covid passports – the questions to ask

Written by | 11 Mar 2022

There are several theoretical reasons for implementing vaccine passports but now that none of these apply any longer in the UK it is difficult to see a rationale… read more.

Covid vaccination – the knowns and unknowns

Written by | 10 Mar 2022

Many factors influence decisions about vaccine use including many ‘unknowns’ and this raises questions about the wisdom of targeting young people and recommending boosters for everyone, explains Allyson… read more.

Mass testing – in theory and in practice

Written by | 9 Mar 2022

There was no evidence that mass testing stopped or prevented the transmission of covid-19, according to Professor Allyson Pollock, Clinical Professor of Public Health, Newcastle University. “Mass testing… read more.

Ivermectin associated with lower mortality than remdesivir

Written by | 8 Mar 2022

An analysis of the records more than 41,000 patients who had covid-19 and were treated with either ivermectin or remdesivir showed that ivermectin was associated with significantly lower… read more.

Evidence-based public health: Covid control measures

Written by | 8 Mar 2022

As the coronavirus pandemic appears to be running out of steam it is important to review the lessons learned and move forward to ‘living with the virus’. IMI… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.